Market Overview

US Stock Futures Down Ahead Of Retail Sales Data

Related SPPI
Spectrum Pharmaceuticals Out-Licenses Rights for Greater China To CASI Pharmaceuticals For Three Of Its Drugs
H.C. Wainwright & Co. Sees Significant Upside Ahead For Spectrum Pharmaceuticals
Related VELT
Velti Intends to Voluntary Delist from NASDAQ
Velti to Sell Mobile Marketing Businesses in US, UK, India to Blackstone's Credit Division

US stock futures are lower this morning, as investors are awaiting retail sales data. Futures for the Dow Jones Industrial Average dropped 17 points to 14,365.00 and S&P 500 index futures fell 1.50 points to 1,544.70. Nasdaq 100 futures declined 4.25 points to 2,793.25.

US stocks closed mostly lower on Tuesday, with the Dow Jones Industrial Average gaining 0.02% to 14,450.06, the S&P 500 index dropping 0.24% to 1,552.48 and the Nasdaq 100 index falling 0.32% to 3,242.32.

The MBA purchase applications index will be released at 7:00 a.m. ET. Data on retail sales for February and import prices for February will be released at 8:30 a.m. ET. Data on business inventories for January will be released at 10:00 a.m. ET, while the EIA weekly report on petroleum inventories will be released at 10:30 a.m. ET.

Spectrum Pharmaceuticals (NASDAQ: SPPI) reported that it expects sales of its drug Fusilev in the range of $10 million to $15 million for the first quarter and $80 million to $90 million for the year.

Velti (NASDAQ: VELT) posted a loss of $5.18 million in the fourth quarter.

Accretive Health (NYSE: AH) is expected to report its Q4 earnings at $0.09 per share on revenue of $236.87 million. Elbit Systems (NASDAQ: ESLT) is estimated to report its Q4 earnings at $0.88 per share on revenue of $838.40 million. Express (NYSE: EXPR) is expected to report its Q4 earnings at $0.74 per share on revenue of $722.38 million.

Vera Bradley (NASDAQ: VRA) is estimated to post its Q4 earnings at $0.57 per share on revenue of $153.18 million. The Men's Wearhouse (NYSE: MW) is projected to post a Q4 loss at $0.05 per share on revenue of $610.00 million. Orexigen Therapeutics (NASDAQ: OREX) is expected to post a Q4 loss at $0.44 per share on revenue of $910.00 thousand.

Coldwater Creek (NASDAQ: CWTR) is projected to post a Q4 loss at $0.79 per share on revenue of $218.76 million. Sigma Designs (NASDAQ: SIGM) is expected to post a Q4 loss at $0.25 per share on revenue of $43.43 million.

European markets were lower today. The STOXX Europe 600 Index fell 0.41%, London's FTSE 100 Index dropped 0.73%, French CAC 40 Index fell 0.36% and German DAX 30 index dropped 0.09%.

Asian markets ended lower, with Japan's Nikkei Stock Average dropping 0.61%, China's Shanghai Composite falling 0.99% and Australia's S&P/ASX 200 dropping 0.47%. Hong Kong's Hang Seng Index declined 1.46% and India's Sensex dropped 1.03%.

Crude-oil futures gained 0.36% to trade at $92.87.

Posted-In: US Stock FuturesNews Futures Global Pre-Market Outlook Markets

 

Related Articles (CWTR + AH)

Around the Web, We're Loving...

Get Benzinga's Newsletters